Company Name: |
Borenpharm Co., Ltd
|
Tel: |
027-65563561 |
Email: |
sales@borenpharm.com |
Products Intro: |
Product Name:Bromo-PEG7-alcohol CAS:86220-35-1 Purity:95% HPLC Package:1g; 5g
|
Br-PEG7-OH manufacturers
- Br-PEG7-OH
-
- $0.00 / 5g
-
2024-03-25
- CAS:86220-35-1
- Min. Order: 5g
- Purity: >98.00%
- Supply Ability: 5g
|
| Br-PEG7-OH Basic information |
Product Name: | Br-PEG7-OH | Synonyms: | Br-PEG7-OH;20-Bromo-3,6,9,12,15,18-hexaoxaicosan-1-ol;Br-PEG7-OH/3,6,9,12,15,18-Hexaoxaeicosan-1-ol, 20-bromo-;3,6,9,12,15,18-Hexaoxaeicosan-1-ol, 20-bromo-;2-[2-[2-[2-[2-[2-(2-bromoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol | CAS: | 86220-35-1 | MF: | C14H29BrO7 | MW: | 389.28 | EINECS: | | Product Categories: | | Mol File: | 86220-35-1.mol | |
| Br-PEG7-OH Chemical Properties |
Boiling point | 443.0±40.0 °C(Predicted) | density | 1.261±0.06 g/cm3(Predicted) | form | Liquid | pka | 14.36±0.10(Predicted) | color | Colorless to light yellow |
| Br-PEG7-OH Usage And Synthesis |
Biological Activity | Bromo-PEG7-alcohol is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | References | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
| Br-PEG7-OH Preparation Products And Raw materials |
|